# N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media

> **NCT00956748** · PHASE4 · WITHDRAWN · sponsor: **St. Paul's Hospital, Canada**

## Conditions studied

- Otitis Media
- Otorrhea

## Interventions

- **DRUG:** Ciprodex
- **DRUG:** Ciprodex and 2% NAC

## Key facts

- **NCT ID:** NCT00956748
- **Lead sponsor:** St. Paul's Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-11-29
- **Primary completion:** 2019-11-29
- **Final completion:** 2019-11-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of staff, time, and resources
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00956748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00956748, "N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00956748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*